Advanced Glycation End Product (AGE) and Soluble Receptor of AGE (sRAGE) Levels in Relation to Periodontitis Severity and as Putative 3-Year Outcome Predictors in Patients Undergoing Coronary Artery Bypass Grafting (CABG).

MLA

Reichert, Stefan, et al. “Advanced Glycation End Product (AGE) and Soluble Receptor of AGE (SRAGE) Levels in Relation to Periodontitis Severity and as Putative 3-Year Outcome Predictors in Patients Undergoing Coronary Artery Bypass Grafting (CABG).” Journal of Clinical Medicine, vol. 11, no. 14, July 2022, p. 4105. EBSCOhost, https://doi.org/10.3390/jcm11144105.

APA

Reichert, S., Hofmann, B., Kohnert, M., Santos, A. N., Friebe, L., Grollmitz, J., Schaller, H.-G., & Schulz, S. (2022). Advanced Glycation End Product (AGE) and Soluble Receptor of AGE (sRAGE) Levels in Relation to Periodontitis Severity and as Putative 3-Year Outcome Predictors in Patients Undergoing Coronary Artery Bypass Grafting (CABG). Journal of Clinical Medicine, 11(14), 4105. https://doi.org/10.3390/jcm11144105

Chicago

Reichert, Stefan, Britt Hofmann, Michael Kohnert, Alexander Navarrete Santos, Lisa Friebe, Julia Grollmitz, Hans-Günter Schaller, and Susanne Schulz. 2022. “Advanced Glycation End Product (AGE) and Soluble Receptor of AGE (SRAGE) Levels in Relation to Periodontitis Severity and as Putative 3-Year Outcome Predictors in Patients Undergoing Coronary Artery Bypass Grafting (CABG).” Journal of Clinical Medicine 11 (14): 4105. doi:10.3390/jcm11144105.